Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600216 stock hub

SHA/600216 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600216is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.5B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600216

In the news

Latest news · SHA/600216

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.1

P25 17.1P50 24.2P75 37.8

Trailing P/E18.3

P25 23.5P50 41.3P75 83.2

ROE5.6

P25 -0.9P50 4.1P75 8.8

ROIC6.7

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600216 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

CNY

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	5,417
Employees Change	-398%
Employees Change Percent	-6.84
Enterprise value	CNY 11.4B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE0000010J2
Last refreshed	2026-05-10
Market cap	CNY 13.5B
Price	CNY 14.28
Price currency	CNY
Rev Per Employee	1,627,483.37x
Sector	Healthcare
Sic	2834
Symbol	sha/600216
Website	https://www.zmc.top

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.55%
EV Earnings	15.14x
EV/EBIT	15.27x
EV/EBITDA	7.83x
EV/FCF	9.43x
EV/Sales	1.29x
FCF yield	8.92%
Forward P/E	12.09x
P/B ratio	1.19x
P/E ratio	18.28x
P/S ratio	1.54x
PE Ratio10 Y	33.44x
PE Ratio3 Y	17.97x
PE Ratio5 Y	18.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.45%
EBITDA Margin	16.47%
FCF margin	13.69%
Gross margin	30.46%
Gross Profit	CNY 2.7B
Gross Profit Growth	-33.25%
Gross Profit Growth Q	-21.53%
Gross Profit Growth3 Y	2%
Gross Profit Growth5 Y	-4.34%
Net Income	CNY 751.3M
Net Income Growth	-48.54%
Net Income Growth Q	-29.84%
Net Income Growth Years	0%
Net Income Growth3 Y	24.15%
Net Income Growth5 Y	-2.11%
Pretax Margin	9.12%
Profit Margin	8.52%
Profit Per Employee	CNY 138,694
Profitable Years	30
ROA	3.31
Roa5y	3.74
ROCE	6.18
ROE	5.6
Roe5y	6.73
ROIC	6.66
Roic5y	7.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.81%
Cagr15y	-0.1%
Cagr1y	8.46%
Cagr20y	11.35%
Cagr3y	8.71%
Cagr5y	-0.53%
Div CAGR10	22.16%
Div CAGR3	29.59%
Div CAGR5	9.98%
EPS Growth	-49.3
EPS Growth Q	-30.23
EPS Growth Years	0
EPS Growth3 Y	24.02
EPS Growth5 Y	-2.41
FCF Growth	42.64%
FCF Growth5 Y	18.27%
OCF Growth	11.68%
OCF Growth Q	-67.2%
OCF Growth10 Y	58.74%
OCF Growth3 Y	32.81%
OCF Growth5 Y	8.4%
Revenue Growth	-6.03x
Revenue Growth Q	-2.86x
Revenue Growth Years	0x
Revenue Growth3 Y	3.55x
Revenue Growth5 Y	1.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.63
Assets	CNY 14.2B
Cash	CNY 3.2B
Current Assets	CNY 7.2B
Current Liabilities	CNY 2.1B
Debt	CNY 957.3M
Debt EBITDA	CNY 0.66
Debt Equity	CNY 0.08
Debt FCF	CNY 0.79
Equity	CNY 11.4B
Interest Coverage	30.03
Liabilities	CNY 2.8B
Long Term Assets	CNY 7B
Long Term Liabilities	CNY 702M
Net Cash	CNY 2.3B
Net Cash By Market Cap	CNY 16.86
Net Cash Growth	33.35%
Net Debt EBITDA	CNY -1.57
Net Debt Equity	CNY -0.2
Net Debt FCF	CNY -1.89
Tangible Book Value	CNY 10.6B
Tangible Book Value Per Share	CNY 11.1
WACC	6.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.39
Inventory Turnover	3.2
Net Working Capital	CNY 2.3B
Quick ratio	2.44
Working Capital	CNY 5B
Working Capital Turnover	CNY 1.86

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.91%
Dividend Growth	146.67%
Dividend Growth Years	1%
Dividend per share	CNY 0.28
Dividend Years	20
Dividend Yield	1.96%
Ex Div Date	2025-07-21
Last Dividend	CNY 0.37
Payout Frequency	Annual
Payout Ratio	50%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	31.96%
1Y total return	8.45%
200-day SMA	15.02
3Y total return	28.49%
50-day SMA	15.83
50-day SMA vs 200-day SMA	50over200
5Y total return	-2.62%
All Time High	23.56
All Time High Change	-39.38%
All Time High Date	2010-04-22
All Time Low	1.15
All Time Low Change	1,142.82%
All Time Low Date	2005-03-23
ATR	0.43
Beta	0.41
Beta1y	-0.35
Beta2y	-0.06
Ch YTD	3.03
High	14.35
High52	18.58
High52 Date	2026-03-09
High52ch	-23.14%
Low	14.2
Low52	13.29
Low52 Date	2025-05-12
Low52ch	7.45%
Ma50ch	-9.79%
Price vs 200-day SMA	-4.93%
RSI	35.68
RSI Monthly	49.75
RSI Weekly	43.64
Sharpe ratio	0.33x
Sortino ratio	0.73
Total Return	1.05%
Tr YTD	3.03
Tr15y	-1.47%
Tr1m	-12.77%
Tr1w	-0.35%
Tr3m	-8.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 745.4M
Operating Income Growth	-53.39
Operating Income Growth Q	-25.64
Operating Income Growth3 Y	36.54
Operating Income Growth5 Y	-4.97
Operating margin	8.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	572,349,984%
Net Borrowing	160,310,489
Shares Institutions	11.17%
Shares Out	947,914,550
Shares Qo Q	2.46%
Shares Yo Y	0.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1.2B
Average Volume	24,252,975.8x
Bv Per Share	11.75
CAPEX	CNY -473.6M
Ch10y	10.27
Ch15y	-24.77
Ch1m	-12.77
Ch1w	-0.35
Ch1y	5.86
Ch20y	512.1
Ch3m	-8.46
Ch3y	21.84
Ch5y	-11.03
Ch6m	-4.23
Change	0.49%
Change From Open	0.35
Close	14.21
Days Gap	0.14
Depreciation Amortization	706,827,687
Dollar Volume	166,960,032.1
Earnings Date	2026-04-11
EBIT	CNY 745.4M
EBITDA	CNY 1.5B
EPS	CNY 0.78
F Score	5
FCF	CNY 1.2B
FCF EV Yield	10.61x
FCF Per Share	CNY 1.27
Financing CF	-317,754,861
Fiscal Year End	December
Founded	1,997
Graham Number	14.36966
Graham Upside	0.63
Income Tax	CNY 171.1M
Investing CF	-640,039,314
Is Primary Listing	1
Last Earnings Date	2026-04-11
Last Report Date	2026-03-31
Last Split Date	2013-10-09
Last Split Type	Forward
Lynch Fair Value	CNY 3.91
Lynch Upside	-72.65
Ma150	14.85
Ma150ch	-3.83%
Ma20	15
Ma20ch	-4.79%
Net CF	759,668,084
Next Earnings Date	2026-08-25
Open	14.23
P FCF Ratio	11.21
P OCF Ratio	8.05
Payment Date	2025-07-21
Position In Range	53.33
Ppne	5,807,445,381
Price Date	2026-05-08
Price EBITDA	CNY 9.32
Ptbv Ratio	1.27
Relative Volume	0.46x
Revenue	8,816,077,404x
Tax By Revenue	1.94x
Tax Rate	21.26%
Tr20y	757.82%
Tr6m	-4.23%
Volume	11,691,879

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600216 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$0.28 annual per share

Payout ratio

+50.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.0%

1 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2025-07-21

Performance

SHA/600216 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600216?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

SHA/600216 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.7

Neutral momentum band

Price vs 200-day MA

-4.9%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600216

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600216 stock rating?

sha/600216 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600216 analysis?

The full report lives at /stocks/sha/600216/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600216?

The latest report frames sha/600216 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600216 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.